A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless of prior immunity or age. The study was published March 15, 2023, in Lancet ID.
“Among Kaiser Permanente members in Southern California who tested positive for coronavirus infection, receiving Paxlovid within 5 days of the start of COVID-19 symptoms was associated with substantial reductions in the risk of hospital admission or death,” said Sara Tartof, PhD, the senior author of the study and an epidemiologist with the Kaiser Permanente Southern California Department of Research & Evaluation. “These findings are even more notable because in this population with high levels of vaccination, we still see additional benefits of this treatment.”
Paxlovid is an oral therapeutic drug aimed at reducing the risk for severe outcomes of coronavirus infection. It is manufactured by Pfizer Inc. It currently has emergency use authorization by the U.S. Food and Drug Administration for adults and children 12 and older who are at high risk for progression to severe COVID-19.
The study analyses included patients with positive results from coronavirus tests undertaken in outpatient settings between April 8 and October 7, 2022. In the study population, 7,274 people had received Paxlovid, and 126,152 had not received Paxlovid. It was a time dominated by the omicron subvariants BA.2, BA.4, and BA.5. Overall, 86% of the 133,426 participants had received 2 COVID-19 vaccine doses, and 61% had received 3 or more.
The study found:
“Our data showed that the sooner people take Paxlovid upon symptom onset, the more effective the medication can be,” Tartof said. “However, there is still some benefit to treatment 6 or more days after symptom onset. People should talk with their doctors about the best approach for them.”
Six steps help you prep for winter trips.
Nearsightedness, also known as myopia, is on the rise. To reverse that …
The updated vaccine is recommended for everyone 6 months and older.
Stories in the Department of Research & Evaluation 2022 Annual Report demonstr …
A new location-based vaccine strategy by Kaiser Permanente was successful …
Kaiser Permanente researchers led analysis of large, diverse group of young …
Vaccinations, testing, and treatment are still widely accessible. Member …
Testing is the most important way you can help control the spread of COVID-19.
With the COVID-19 public health emergency ending, states, community organizati …
Kaiser Permanente offers many high-quality, convenient options to help …
Learning from this historic health crisis will better prepare us for future …
From avid snowboarder to chronically ill patient. How Kaiser Permanente …
Almost 16 million people in the United States have chronic obstructive …
Two leading infectious disease physicians discuss what to expect with COVID-19 …
Kaiser Permanente study shows that exercise is associated with lower rates …
As colder weather and rain arrive in Oregon, Katie Sharff, MD, an infectious …
New care option offers pregnant patients a mix of in-person and video visits.
A Kaiser Permanente study of more than 250,000 people shows that patients …
Kaiser Permanente study finds vaccinated surgical patients had no elevated …
Providing safe and effective vaccinations to children is an important step …
We donated over $28 million worth of face masks, hand sanitizer, and other …
Two years into the COVID-19 pandemic, a Kaiser Permanente pediatrician …
Kaiser Permanente grants are supporting businesses such as the Carefree …
Grants expand support for faith-based organizations working to protect …
After serving on the White House COVID-19 response team, Bechara Choucair, …
Kaiser Permanente and other leading companies are mandating COVID-19 shots …
A statement from Kaiser Permanente chair and chief executive officer Greg …
Kaiser Permanente’s partnership with Local Initiatives Support Corporation, …
For people without a safe place to call home, good health is often out …
Video visits and virtual collaboration speed cancer care transformation …
Kaiser Permanente study finds that the decrease reported during the onset …
Kaiser Permanente research underscores the importance of culturally appropriat …
As vaccines bring hope to end the pandemic, Kaiser Permanente’s toolkit …
A statement from CEO Greg A. Adams about the American Rescue Plan Act.
Available 24/7 with no appointment, e-visits offer Kaiser Permanente members …
A diabetes specialist talks about new trends in providing care, and innovation …
Health care system provides model for screening patients for access to …
With expanded telehealth options, Kaiser Permanente members get convenient …
Skilled care and thorough infection-prevention protocols kept Eleanor Gorman …
Kaiser Permanente scientists and clinicians are running clinical trials …
Kaiser Permanente pledges more than $28 million in grants, many to address …
Newsweek’s Best Maternity Care Hospitals 2020 report recognizes Kaiser …
Kaiser Permanente is part of a phase 1 trial testing a vaccine designed …
Kaiser Permanente’s fully integrated telehealth capabilities place quality …
Helping people strengthen connections, maintain healthy routines, and find …
New Kaiser Permanente research backs anecdotal reports that people are …
Kaiser Permanente nurses have been saving lives on the front lines since …